Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2010-02-17 PRENTKI RONALD J President & CEO Grant or award · Incentive Stock Option (right to buy) +217,668 217,668
2010-02-17 PRENTKI RONALD J President & CEO Grant or award · Non-Qualified Stock Option (right to buy) +32,332 32,332
2010-02-17 Whelan John CFO Grant or award · Incentive Stock Option (right to buy) +93,177 93,177
2010-02-17 Whelan John CFO Grant or award · Non-Qualified Stock Option (right to buy) +56,823 56,823
2010-02-17 BARR JOHN Vice President of R&D Grant or award · Incentive Stock Option (right to buy) +150,000 150,000
2010-02-17 ROSENBLATT TOBY Director Grant or award +14,042 114,343
2010-02-17 GODDARD PAUL Director Grant or award +14,042 118,792
2010-02-17 ZERBE ROBERT L MD Director Grant or award +14,042 106,181
2010-02-17 TURNBULL GREG Director Grant or award +14,042 149,201
2009-10-19 TANG KEVIN C Director Purchase +2,443,181 $0.88 $2.1M 10,436,506
2009-10-19 TANG KEVIN C Director Purchase · Purchase Rights (right to buy) +1,586,481 $0.13 $198K 1,586,481
2009-10-19 TANG KEVIN C Director Purchase · Warrants (right to buy) +1,221,590 $0.13 $153K 1,221,590
2009-07-08 PRENTKI RONALD J President & CEO Grant or award +63,095 63,095
2009-07-08 PRENTKI RONALD J President & CEO Returned to the company −22,556 $0.90 $20K 40,539
2009-05-27 ZERBE ROBERT L MD Director Grant or award +70,000 92,139
2009-05-27 GODDARD PAUL Director Grant or award +70,000 104,750
2009-05-27 TURNBULL GREG Director Grant or award +70,000 135,159
2009-05-27 ROSENBLATT TOBY Director Grant or award +70,000 100,301
2009-02-23 Whelan John CFO Grant or award · Incentive Stock Option (right to buy) +350,000 350,000
2009-01-16 BARR JOHN Vice President of R&D Grant or award · Non-Qualified Stock Option (right to buy) +160,000 160,000

Page 43 of 45 · 881 trades